Pacific Biosciences of California (PACB)
(Delayed Data from NSDQ)
$1.77 USD
+0.05 (2.91%)
Updated May 10, 2024 04:00 PM ET
After-Market: $1.79 +0.02 (1.13%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2024
Time: -- |
6/2024 | $-0.24 | 8.33% |
Earnings Summary
For their last quarter, Pacific Biosciences of California (PACB) reported earnings of -$0.26 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for PACB's next earnings release expected on August 07, 2024. For the next earning release, we expect the company to report earnings of -$0.24 per share, reflecting a year-over-year increase of 7.69%.
Earnings History
Price & Consensus
Zacks News for PACB
Pacific Biosciences (PACB) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
PACB: What are Zacks experts saying now?
Zacks Private Portfolio Services